Jack Lawler

Jack Lawler

Harvard University

H-index: 90

North America-United States

About Jack Lawler

Jack Lawler, With an exceptional h-index of 90 and a recent h-index of 38 (since 2020), a distinguished researcher at Harvard University, specializes in the field of thrombospondins, angiogenesis, cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract A040: Assessing the ability of Fc3TSR to remodel the tumor microenvironment and enhance efficacy of immunotherapies and chemotherapy in a murine model of pancreatic …

Thrombospondins in the tumor microenvironment

The tyrosine kinase inhibitor lenvatinib inhibits anaplastic thyroid carcinoma growth by targeting pericytes in the tumor microenvironment

Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1

Fc3TSR improves intratumoral treatment delivery by normalizing tumor vasculature and reducing interstitial fluid pressure in an orthotopic, syngeneic mouse model of epithelial …

Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse …

Endothelial cell behavior is determined by receptor clustering induced by thrombospondin-1

Normalizing tumor vasculature to reduce hypoxia, enhance perfusion, and optimize therapy uptake

Jack Lawler Information

University

Position

Harvard Medical School

Citations(all)

30796

Citations(since 2020)

5417

Cited By

26866

hIndex(all)

90

hIndex(since 2020)

38

i10Index(all)

209

i10Index(since 2020)

114

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Jack Lawler Skills & Research Interests

thrombospondins

angiogenesis

cancer

Top articles of Jack Lawler

Title

Journal

Author(s)

Publication Date

Abstract A040: Assessing the ability of Fc3TSR to remodel the tumor microenvironment and enhance efficacy of immunotherapies and chemotherapy in a murine model of pancreatic …

Cancer Research

Bianca Garlisi

Caroline Aitken

Sylvia Lauks

Julia Stewart

Duncan Petrik

...

2024/1/16

Thrombospondins in the tumor microenvironment

James Petrik

Sylvia Lauks

Bianca Garlisi

Jack Lawler

2023/6/5

The tyrosine kinase inhibitor lenvatinib inhibits anaplastic thyroid carcinoma growth by targeting pericytes in the tumor microenvironment

Thyroid

Asumi Iesato

Stephanie Li

Peter M Sadow

Mohammadreza Abbasian

Ara Nazarian

...

2023/7/1

Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1

Jack Lawler

2022/11/1

Fc3TSR improves intratumoral treatment delivery by normalizing tumor vasculature and reducing interstitial fluid pressure in an orthotopic, syngeneic mouse model of epithelial …

Cancer Research

Kathy Matuszewska

Madison Pereira

Leslie Ogilvie

Duncan Petrik

Allison Gartung

...

2022/6/15

Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse …

Gynecologic Oncology

Kathy Matuszewska

Simone Ten Kortenaar

Madison Pereira

Lisa A Santry

Duncan Petrik

...

2022/1/1

Endothelial cell behavior is determined by receptor clustering induced by thrombospondin-1

Verônica Morandi

Jim Petrik

Jack Lawler

2021/3/29

Normalizing tumor vasculature to reduce hypoxia, enhance perfusion, and optimize therapy uptake

Kathy Matuszewska

Madison Pereira

Duncan Petrik

Jack Lawler

Jim Petrik

2021/9/3

Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAFV600E: New Insights in the Host Tissue …

Frontiers in Endocrinology

Mark Duquette

Peter M Sadow

Jack Lawler

Carmelo Nucera

2020/10/9

AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma

Cancer gene therapy

Darrick L Yu

Ashley A Stegelmeier

Natalie Chow

Amira D Rghei

Kathy Matuszewska

...

2020/5

Pro‐Resolving Lipid Mediators and Anti‐Angiogenic Therapy Exhibit Synergistic Anti‐Tumor Activity via Resolvin Receptor Activation

The FASEB Journal

Victoria M Hallisey

Franciele C Kipper

Justin Moore

Allison Gartung

Diane R Bielenberg

...

2020/4

See List of Professors in Jack Lawler University(Harvard University)